Rivaroxaban Market Size, Share, and Industry Analysis, By Product (Xarelto and Others), By Strength (2.5 mg, 10 mg, 15 mg, 20 mg, and 1 mg/mL), By Dosage Form (Tablets and Oral Suspension), By Type (Branded and Generic), By Disease Indication (Deep Vein Thrombosis, Pulmonary Embolism, Coronary Artery Disease, Peripheral Artery Disease, Thromboprophylaxis, and Others), By Age Group (Pediatric and Adults), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, and Online Pharmacies), and Regional Forecast till 2034